Nirmala Gonsalves

Nirmala Gonsalves

Auto-generated profile, based on publicly available information

Nirmala Gonsalves

Kenneth C. Griffin Esophageal Center of Northwestern Medicine, Division of Gastroenterology and Hepatology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2011 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
CLChris A. Liacouras
Chris A. Liacouras
GFGlenn T. Furuta
Glenn T. Furuta
IHIkuo Hirano
Ikuo Hirano
DADan Atkins
Dan Atkins
SAStephen E. Attwood
Stephen E. Attwood
SASeema S. Aceves
Seema S. Aceves

1 May 2013 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
EDEvan S Dellon
Evan S Dellon
NGNirmala Gonsalves
Nirmala Gonsalves
IHIkuo Hirano
Ikuo Hirano
GFGlenn T Furuta
Glenn T Furuta
CLChris A Liacouras
Chris A Liacouras
DKDavid A Katzka
David A Katzka
Esophageal eosinophilia and eosinophilic esophagitis (EoE) are increasingly recognized and prevalent conditions, which now represent common clinical problems encountered by gastroenterologists, pathologists, and allergists. The study of EoE has become a dynamic field with an evolving understanding of the pathogenesis, diagnosis, and treatment. Although there are limited data supporting management decisions, clinical parameters are needed to guide the care of patients with eosinophilic-esophageal disorders. In this evidence-based review, recommendations developed by adult and pediatric gastroenterologists are provided for the evaluation and management of these patients. New terminology is emphasized, particularly the concepts of esophageal eosinophilia and proton-pump inhibitor-responsive esophageal eosinophilia (PPI-REE) as entities distinct from EoE.

22 May 2012 in Gut
Verified
Journal Article
Closed access
PDF file
IHIkuo Hirano
Ikuo Hirano
NMNelson Moy
Nelson Moy
MHMichael G Heckman
Michael G Heckman
CTColleen S Thomas
Colleen S Thomas
NGNirmala Gonsalves
Nirmala Gonsalves
SASami R Achem
Sami R Achem
Objective Abnormalities are commonly identified during endoscopy in eosinophilic oesophagitis (EoE). There is no standardised classification to describe these features. This study aimed to evaluate the interobserver agreement of a grading system for the oesophageal features of EoE. Method The proposed system incorporated the grading of four major oesophageal features (rings, furrows, exudates, oedema) and the presence of additional features of narrow calibre oesophagus, feline oesophagus, stricture and crepe paper oesophagus. Endoscopic videos from 25 patients with EoE and controls were reviewed by 21 gastroenterologists. Interobserver agreement was assessed by estimating multi-rater κ and the proportion of pairwise agreement. Results Using the original grading system, agreement for rings, furrows and exudates was moderate (κ=0.38–0.46, 56–65% agreement) but poor for oedema (κ=0.23, 51% agreement). Identification of narrow calibre oesophagus had fair agreement (κ=0.30, 74% agreement) while feline oesophagus had poor agreement (κ=0.15, 68% agreement). After collapsing the severity grading for oedema and furrows and eliminating poorly performing features of feline oesophagus and narrow calibre oesophagus, a modified grading system demonstrated good agreement for the four major features of EoE (κ=0.40–0.54, 71–81% agreement) and additional features of stricture and crepe paper oesophagus (κ=0.52 and 0.58, 79% and 92% agreement). Conclusions The proposed system for endoscopically-identified oesophageal features of EoE defines common nomenclature and severity scores for the assessment of EoE disease activity. The system has good interobserver agreement among practising and academic gastroenterologists.

1 June 2012 in Gastroenterology
Verified
Journal Article
Closed access
NGNirmala Gonsalves
Nirmala Gonsalves
GYGuang–Yu Yang
Guang–Yu Yang
BDBethany Doerfler
Bethany Doerfler
SRSally Ritz
Sally Ritz
ADAnne M. Ditto
Anne M. Ditto
IHIkuo Hirano
Ikuo Hirano

1 September 2006 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
NGNirmala Gonsalves
Nirmala Gonsalves
MPMaria Policarpio-Nicolas
Maria Policarpio-Nicolas
QZQing Zhang
Qing Zhang
MRM. Sambasiva Rao
M. Sambasiva Rao
IHIkuo Hirano
Ikuo Hirano

1 March 2016 in Gastroenterology
Verified
Journal Article
Open access
PDF file
ESEkaterina Safroneeva
Ekaterina Safroneeva
ASAlex Straumann
Alex Straumann
MCMichael Coslovsky
Michael Coslovsky
MZMarcel Zwahlen
Marcel Zwahlen
CKClaudia E. Kuehni
Claudia E. Kuehni
KYKathleen J. Yost
Kathleen J. Yost
Background & Aims It is not clear whether symptoms alone can be used to estimate the biologic activity of eosinophilic esophagitis (EoE). We aimed to evaluate whether symptoms can be used to identify patients with endoscopic and histologic features of remission. Methods Between April 2011 and June 2014, we performed a prospective, observational study and recruited 269 consecutive adults with EoE (67% male; median age, 39 years old) in Switzerland and the United States. Patients first completed the validated symptom-based EoE activity index patient-reported outcome instrument and then underwent esophagogastroduodenoscopy with esophageal biopsy collection. Endoscopic and histologic findings were evaluated with a validated grading system and standardized instrument, respectively. Clinical remission was defined as symptom score <20 (range, 0−100); histologic remission was defined as a peak count of <20 eosinophils/mm2 in a high-power field (corresponds to approximately <5 eosinophils/median high-power field); and endoscopic remission as absence of white exudates, moderate or severe rings, strictures, or combination of furrows and edema. We used receiver operating characteristic analysis to determine the best symptom score cutoff values for detection of remission. Results Of the study subjects, 111 were in clinical remission (41.3%), 79 were in endoscopic remission (29.7%), and 75 were in histologic remission (27.9%). When the symptom score was used as a continuous variable, patients in endoscopic, histologic, and combined (endoscopic and histologic remission) remission were detected with area under the curve values of 0.67, 0.60, and 0.67, respectively. A symptom score of 20 identified patients in endoscopic remission with 65.1% accuracy and histologic remission with 62.1% accuracy; a symptom score of 15 identified patients with both types of remission with 67.7% accuracy. Conclusions In patients with EoE, endoscopic or histologic remission can be identified with only modest accuracy based on symptoms alone. At any given time, physicians cannot rely on lack of symptoms to make assumptions about lack of biologic disease activity in adults with EoE. ClinicalTrials.gov, Number: NCT00939263.